Abstract
The therapeutic impact is described with the combined use of two medications with different anti-corticosteroid actions in the clinical resolution of a patient with chronic central serous chorioretinopathy.
Keywords:
Central serous chorioretinopathy/drug therapy; Adrenal cortex hormones/therapeutic use; Combined modality therapy; Case reports